Titelia

Holdings of Commodore Capital LP

· Original filing · Compare with another fund · Report an error

Net assets
-
Positions
30 in 1 countries
Top ten
68.7 % of the equity sleeve
Filed on
Mar 31, 2026
Portfolio shape

Positions

RankCompanySharesValueWeight
1Relay Therapeutics Inc 17,000,000169.2M $
2Enliven Therapeutics Inc 3,275,000128.4M $
3Cogent Biosciences Inc 2,888,007111.2M $
4Spyre Therapeutics Inc 1,912,38096.5M $
5Tyra Biosciences Inc 2,475,00094.8M $
6Celldex Therapeutics Inc 2,696,61685.5M $
7Nuvalent Inc 833,60085.4M $
8Amylyx Pharmaceuticals Inc 5,650,00078.5M $
9Kymera Therapeutics Inc 750,00062.5M $
10Alto Neuroscience Inc 2,723,19661.2M $
11Erasca Inc 3,175,00051.4M $
12DAMORA THERAPEUTICS INC 1,939,00050.2M $
13LB Pharmaceuticals Inc 1,500,00037M $
14EyePoint Inc 2,825,00036.4M $
15Nurix Therapeutics Inc 2,275,00035.3M $
16Corvus Pharmaceuticals Inc 2,258,73533M $
17Assembly Biosciences Inc 1,000,00027.8M $
18Perspective Therapeutics Inc 6,336,78226.4M $
19Soleno Therapeutics Inc 652,43221.8M $
20Ocular Therapeutix Inc 2,575,00021.8M $
21Century Therapeutics Inc 8,695,65219.7M $
22SAB Biotherapeutics Inc 4,401,50016.9M $
23Palisade Bio Inc 7,181,06212.6M $
24Karyopharm Therapeutics Inc 1,950,00010.9M $
25Inhibikase Therapeutics Inc 5,397,4889.1M $
26AN2 Therapeutics Inc 2,333,7138M $
27PepGen Inc 4,475,0007.9M $
28AVALO THERAPEUTICS INC 483,0007.2M $
29LeonaBio Inc 464,3984.8M $
30Relmada Therapeutics Inc 633,9014.4M $

Download this table: CSV, JSON

Sector breakdown

  • Unattributed 100.0 %

Titelia classification, company by company. The unattributed share stays visible.

Currency breakdown

  • USD 100.0 %

The quoted currency of each line, as declared.

Country breakdown

  • United States 100.0 %

Shares computed on the equity sleeve.

RankCountryLinesValueShare
1United States301.4B $100.00 %
Cite this page

Titelia. "Holdings of Commodore Capital LP". https://titelia.com/en/funds/US13F1831942